CKCynthia L. Kenmuir

Cynthia L. Kenmuir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cynthia L. Kenmuir has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endovascular Therapy in Intracranial Atherosclerotic Stenosis-Related Large Vessel Occlusion Stroke: A Brief Practice Update and Consensus Statement From the SVIN

    by Sami Al Kasab, Ahmad Abu Qdais, Shadi Yaghi, Waldo R. Guerrero, Shahram Majidi, Mohamad Abdalkader, Kaustubh Limaye, Osama O. Zaidat, Adam de Havenon, David S. Liebeskind, et al.

    Intracranial atherosclerotic stenosis–related large vessel occlusion (ICAS-LVO) represents a distinct subset of acute ischemic stroke with unique diagnostic and therapeutic challenges during endovascular therapy. Compared with embolic LVO, ICAS-LVO is associated with higher rates of reocclusion and the frequent use of adjunctive interventions. This Brief Practice Update summarizes current evidence and expert consensus to guide the identification and management of ICAS-LVO during endovascular therapy. The Society of Vascular and Interventional Neurology Guidelines and Practice Standards committee convened a multidisciplinary writing group of neurointerventionalists to review available literature and define key clinical questions on ICAS-LVO and endovascular therapy. Evidence was appraised using the Society of Vascular and Interventional Neurology framework for Class of Recommendation and Level of Evidence, adapted from the American College of Cardiology/American Heart Association. Draft statements were iteratively refined and approved by the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Quality Committee for adherence to internal standards and endorsed by the Society of Vascular and Interventional Neurology Board of Directors. Evidence was derived from randomized trials, multicenter registries, cohort studies, post hoc analyses, and meta-analyses addressing diagnostic features, first-line thrombectomy strategies, and adjunctive therapies in ICAS-LVO. Both stent retriever and direct aspiration approaches are acceptable initial strategies; however, durable recanalization is only achieved in about half of patients. Adjunctive use of intravenous or intra-arterial glycoprotein IIb/IIIa inhibitors, balloon angioplasty, and rescue stenting has demonstrated improved recanalization rates and favorable functional outcomes in observational studies, without increased hemorrhagic complications. However, the quality of evidence remains weak. A summary of recommendations is provided to guide practice in common procedural scenarios. This Brief Practice Update provides evidence-based and expert consensus recommendations for the diagnosis and endovascular treatment of ICAS-LVO. Management should be individualized by incorporating the clinical presentation, imaging characteristics, and operator expertise. While adjunctive therapy may be beneficial in select cases, high-quality randomized trials are needed to define optimal strategies and establish standardized algorithms for this challenging stroke subtype.

  • Open Access

    Endovascular Thrombectomy in Medium and Distal Vessel Occlusions: A Focused Guideline From the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee

    by Shahram Majidi, Amol Mehta, Sami Al-Kasab, Kaustubh Limaye, Adam A. Dmytriw, Adam de Havenon, Farhan Siddiq, Robin Novakovic, Alexandra L Czap, Ossama Mansour, et al.

    BACKGROUND: The authors present an overview of the current evidence and management recommendations for evaluation and treatment of adults with acute ischemic stroke from distal- and medium-vessel occlusion (DMVO) for endovascular thrombectomy (EVT). The intended audiences are prehospital care providers, physicians, and allied health professionals. METHODS: The Society of Vascular and Interventional Neurology Guidelines and Practice Standards committee formed a writing group to conduct a structured literature review on EVT for DMVO-related acute ischemic stroke and to draft practice recommendations in accordance with the Society of Vascular and Interventional Neurology Guidelines and Practice Algorithm. A structured literature search was conducted across PubMed, MEDLINE, and the Cochrane Library from January 2015 through February 2026, supplemented by manual review of reference lists from key studies and conferences. Recommendations were developed with consensus from an expert panel and the Guidelines and Practice Standards committee, with final approval by the Society of Vascular and Interventional Neurology Board of Directors. RESULTS: Data from all randomized controlled trials, prior meta-analyses, and subgroup analyses were extracted to evaluate the latest evidence on the safety and efficacy of EVT in patients presenting with DMVO acute ischemic stroke. The guideline outlines practical considerations for patient selection, procedural technique, and systems of care. CONCLUSIONS: These guidelines provide focused practical recommendations based on recent evidence regarding patient selection and decision-making for EVT in patients presenting with acute DMVO. Routine EVT for DMVO is not supported by current evidence; however, performing EVT in patients with disabling acute dominant M2 occlusion remains reasonable.


  • Open Access

    Assessing Predictive Factors for Thrombectomy Necessity in Acute Ischemic Stroke: Insights From the Direct to Angio Suite Protocol

    by Whitfield Lewis, Keiko A. Fukuda, Shashvat M. Desai, Cynthia L. Kenmuir, Mohamed Shehab-Eldin, Mausaminben Y. Hathidara, Ashutosh P. Jadhav

    BACKGROUND: Endovascular thrombectomy (EVT) has emerged as an effective treatment option. Unfortunately, interfacility transfers to thrombectomy-capable centers often delay treatment time. The direct to angio suite (DTA) pathway reduces interfacility transfer time by foregoing the emergency department at the thrombectomy-capable center and directing patients immediately to the angio suite. Up to 22% of patients transferred under the DTA pathway will not have a large vessel occlusion on cerebral angiography or will experience significant neurological improvement, obviating the need for EVT. This study evaluated predictive factors associated with EVT under the DTA protocol. METHODS: A retrospective review was conducted on 2590 patients transferred to 2 comprehensive stroke centers from January 2015 to December 2020. Data from 407 patients transferred under the DTA protocol were analyzed to identify factors associated with undergoing EVT using multivariable logistic regression adjusted for age, sex, National Institutes of Health Stroke Scale (NIHSS) score on arrival at the comprehensive stroke center, Alberta Stroke Program Early Computed Tomography Score, decrease in NIHSS score from initial presentation to arrival at the comprehensive stroke center by ≥5 points (change in NIHSS score from referring hospital to comprehensive stroke center), intravenous thrombolytics, and computed tomography angiography–confirmed large vessel occlusion. Statistical analysis included the Mann-Whitney U test, the Fisher exact test, the Pearson χ 2 test, and the logistic regression analysis. RESULTS: Of the 407 patients transferred under the DTA protocol (median age, 73 [interquartile range, 63–82] years; 50% female), 355 underwent EVT, while 52 did not. Among patients who did not undergo EVT, 12 demonstrated significant neurological improvement on arrival, obviating the need for intervention. Among the remaining 40 patients, diagnostic cerebral angiography demonstrated distal clot migration or patent vessels, precluding thrombectomy. Factors associated with EVT included comprehensive stroke center NIHSS score, large vessel occlusion on computed tomography angiography at the satellite hospital, change in NIHSS score from referring hospital to comprehensive stroke center score, intravenous thrombolytics, and Alberta Stroke Program Early Computed Tomography Score. Comprehensive stroke center NIHSS score ≥8 (odds ratio, 5.99) and large vessel occlusion on computed tomography angiography (odds ratio, 5.36) were associated with higher odds of EVT. In contrast, change in NIHSS score from referring hospital to comprehensive stroke center score (odds ratio, 0.38), intravenous thrombolytics (odds ratio, 0.41), and Alberta Stroke Program Early Computed Tomography Score ≥9 (odds ratio, 0.22) were associated with lower odds of EVT. Tenfold cross-validation demonstrated a sensitivity of 96.65%, positive predictive value of 89.15%, and negative predictive value of 65.22%. The full model demonstrated strong discrimination (area under the curve, 0.84). CONCLUSIONS: The study identifies key predictors of EVT under the DTA protocol, highlighting the role of initial clinical assessment and neuroimaging in optimizing patient selection and reducing unnecessary interventions.

  • Open Access

    Consensus Guidelines on Inferior Petrosal Sinus Sampling: A Guideline From the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee

    by Farhan Siddiq, Hunter Brooks, Esra Demirtas, Ibrahim A. Bhatti, Sami Al Kasab, Adam de Havenon, Robin Novakovic, Ossama Y. Mansour, Cynthia L. Kenmuir, Ameer E. Hassan, et al.

    BACKGROUND: Bilateral inferior petrosal sinus sampling (BIPSS) is the gold-standard test to distinguish Cushing disease (CD) from ectopic adrenocorticotropic hormone (ACTH) secretion when biochemistry confirms ACTH-dependent Cushing syndrome and pituitary magnetic resonance imaging is equivocal. However, practice varies widely between centers, leading to false negatives, misinterpretation, sampling errors, and avoidable risk. Neurointerventionalists performing BIPSS have lacked dedicated, procedure-focused guidance. METHODS: Using the Society of Vascular and Interventional Neurology Guidelines and Practice Standards framework, a multidisciplinary panel (endocrinology, interventional neuroradiology, and endovascular neurosurgery) performed a systematic review through August 2025 and developed recommendations graded by class of recommendation and level of evidence through a modified Delphi process. RESULTS: The guideline standardizes (1) indications for BIPSS in biochemically confirmed ACTH-dependent Cushing with normal, equivocal, or <6 mm pituitary lesions; (2) technical approach, including bilateral IPS catheterization, heparinization, and stimulation with corticotropin-releasing hormone or desmopressin; (3) sampling protocol with 2 prestimulation draws and timed collections at 3, 5, 10, and 15 minutes; (4) lab handling, emphasizing prechilled EDTA tubes, rapid ACTH processing, and prolactin measurement as an internal control of venous effluent; and (5) interpretation, using ACTH inferior petrosal sinus to peripheral ratio cutoffs (≥2 prestimulation, ≥3 poststimulation) and techniques to identify potential false negatives. The document also defines operator/institutional competency benchmarks and quality-assurance metrics. CONCLUSIONS: When executed with standardized technique and interpretation, BIPSS offers very high sensitivity and specificity for localizing ACTH pathology. These consensus guidelines provide a practical playbook for neurointerventionalists to perform BIPSS safely, reproducibly, and with maximal diagnostic yield.

  • Open Access

    Safety and Feasibility of a “Fast-Track” Monitoring Protocol for Patients Treated with Intravenous Thrombolytic Therapy

    by Keiko A Fukuda, Kavit Shah, Cynthia Kenmuir, Derrick Barnagian, Baraa Nawash, Mackenzie Nelson, Shashvat Desai, Marcelo Rocha, Matthew Starr, Eileen Roach, et al.

    Introduction Our health care systems continue to face significant strain due to chronically taxed intensive care resources. A subgroup of post-thrombolytic stroke patients may not require prolonged intensive monitoring, alleviating some burden. Here we describe the safety, feasibility, and utility of a Fast-Track Protocol (FTP) for early de-escalation of high-acuity monitoring. Methods We compared a prospective cohort of FTP patients at our stroke centers from April 2020 – February 2022 to a similar retrospective cohort. Those on presentation with NIHSS < 10 and without large vessel occlusion or flow-limiting stenosis, intravenous anti-hypertensive use, and any hemodynamic or respiratory concerns were eligible. Primary outcomes included early neurologic deterioration, defined as worsening of NIHSS ≥ 4-points at 24 hours, parenchymal hemorrhage, and symptomatic intracranial hemorrhage. Results Of 574 thrombolysis patients, 119 (21%) were eligible for FTP. One hundred (88%) were included for analysis. The median ± IQR hospitalization was 2.0 ± 1.6 days. None of the four patients with early neurologic deterioration were due to hemorrhage. No symptomatic intracranial hemorrhages occurred, and no FTP patients were transferred back to the ICU. Median ± IQR 90-day modified Rankin scale was 1 ± 1. Discussion FTP is a safe and feasible strategy to triage ICU patients and decrease unnecessary ICU monitoring. This is important in a post-pandemic era as ICU resources continue to fluctuate. Future studies are needed to establish the optimal level of monitoring in post thrombolytic patients.

  • Secular Increases in Spontaneous Subarachnoid Hemorrhage during Pregnancy: A Nationwide Sample Analysis

    by Kaustubh Limaye, Achint Patel, Mihir Dave, Cynthia Kenmuir, Sourabh Lahoti, Ashutosh P. Jadhav, Edgar A. Samaniego, Santiago Ortega-Gutièrrez, James Torner, David Hasan, et al.


  • Laterality is an Independent Predictor of Endovascular Thrombectomy in Patients With Low National Institute of Health Stroke Scale

    by Shashvat M. Desai, Marcelo Rocha, Matthew Starr, Bradley J. Molyneaux, Cynthia L. Kenmuir, Bradley A. Gross, Brian T. Jankowitz, Tudor G. Jovin, Ashutosh P. Jadhav


  • Open Access

    Update on cell therapy for stroke

    by Cynthia L Kenmuir, Lawrence R Wechsler

    Ischaemic stroke remains a leading cause of death and disability. Current stroke treatment options aim to minimise the damage from a pending stroke during the acute stroke period using intravenous thrombolytics and endovascular thrombectomy; however, there are no currently approved treatment options for reversing neurological damage once a stroke is completed. Preclinical studies suggest that cell therapy may be safe and effective in improving functional outcomes. Several recent clinical trials have reported safety and some improvement in outcomes following cell therapy administration in ischaemic stroke, which are reviewed. Cell therapy may provide a promising new treatment for stroke reducing stroke-related disability. Further investigation is needed to determine specific effects of cell therapy and to optimise cell delivery methods, cell dosing, type of cells used, timing of delivery, infarct size and location of infarct that are likely to benefit from cell therapy.


  • Cerebral venous sinus thrombosis in pregnancy and puerperium: A pooled, systematic review

    by Ahmed I. Kashkoush, Henry Ma, Nitin Agarwal, David Panczykowski, Daniel Tonetti, Gregory M. Weiner, William Ares, Cynthia Kenmuir, Ashutosh Jadhav, Tudor Jovin, et al.